These biochemical findings suggest that an excessive eIF2α phosphorylation is not a universal feature of AD mouse models, such as 5xFAD mice, and they also indicate that the heterozygous eIF2αS51A mutation is not necessarily sufficient to suppress hippocampal eIF2α phosphorylation. This evidence concerns the gene EIF2A and Alzheimer disease.